|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.320 USD | +0.87% |
|
+0.87% | +28.89% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 26/06/2026 | 29/06/2026 | 30/06/2026 | 01/07/2026 | 02/07/2026 | |
|---|---|---|---|---|---|
| Last | US$2.300 | US$2.350 | US$2.330 | US$2.300 | US$2.320 |
| Volume | 2,544,165 | 540,557 | 500,098 | 436,234 | 472,793 |
| Change | +3.60% | +2.17% | -0.85% | -1.29% | +0.87% |
| Opening | US$2.220 | US$2.310 | US$2.360 | US$2.310 | US$2.300 |
| High | US$2.350 | US$2.380 | US$2.360 | US$2.335 | US$2.355 |
| Low | US$2.215 | US$2.255 | US$2.310 | US$2.260 | US$2.270 |
Performance
| 1 day | +0.87% | ||
| 1 week | +0.87% | ||
| Current month | -0.43% | ||
| 1 month | +18.37% | ||
| 3 months | +7.91% | ||
| 6 months | +33.33% | ||
| Current year | +28.89% | ||
| 1 year | +50.65% | ||
| 3 years | +26.09% | ||
| 5 years | +28.89% | ||
| 10 years | -64.47% |
Volumes
marketsDaily volume
472,793
Estimated daily volume
472,793
Avg. Volume 20 sessions
732,632
Daily volume ratio
0.65
Avg. Volume 20 sessions USD
1,699,706.24
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
186,926,209
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
179,677,592
Average Daily Capital Traded
0.91%
Indicators
Moving average 5 days
2.32
Moving average 20 days
2.122
Moving average 50 days
2.082
Moving average 100 days
2.329
Price spread / (MMA5)
0.00%
Price spread / (MMA20)
-8.53%
Price spread / (MMA50)
-10.25%
Price spread / (MMA100)
+0.38%
RSI 9 days
65.37
RSI 14 days
62.54
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +0.87% | +50.65% | +26.09% | 187M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 338B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 299B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 291B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.97% | +4.57% | +33.66% | +55.01% | 369.26B | |
| Weighted average by Cap. | +2.25% | +5.53% | +42.31% | +83.30% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
690a5350c6f9bc7ce1ef5.tAUM_AN8V6w8AnVXdo6KQELHOD00qm371I5OEPgwF3I.wW46kTEfFvp7Vw05T-bjCxf1CGpAzjuhv9skPZZFej3tVXaEcyMI2mt3RQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 21:00:00 | 2.320 | 21,617 | 377,377 |
| 20:59:58 | 2.315 | 206 | 355,760 |
| 20:59:55 | 2.320 | 100 | 355,554 |
| 20:59:55 | 2.315 | 114 | 355,454 |
| 20:59:55 | 2.315 | 120 | 355,340 |
| 20:59:55 | 2.315 | 184 | 355,220 |
| 20:59:53 | 2.315 | 130 | 355,036 |
| 20:59:53 | 2.315 | 300 | 354,906 |
| 20:59:50 | 2.320 | 100 | 354,606 |
| 20:59:50 | 2.320 | 600 | 354,506 |
Course Extremes
| 1 week | 2.26 |  | 2.38 |
| 1 month | 1.94 | | 2.38 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.36 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +28.89% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
